Literature DB >> 16611914

Sendai virus infection induces efficient adaptive immunity independently of type I interferons.

Carolina B López1, Jacob S Yount, Tamar Hermesh, Thomas M Moran.   

Abstract

Adaptive immunity in response to virus infection involves the generation of Th1 cells, cytotoxic T cells, and antibodies. This type of immune response is crucial for the clearance of virus infection and for long-term protection against reinfection. Type I interferons (IFNs), the primary innate cytokines that control virus growth and spreading, can influence various aspects of adaptive immunity. The development of antiviral immunity depends on many viral and cellular factors, and the extent to which type I IFNs contribute to the generation of adaptive immunity in response to a viral infection is controversial. Using two strains (Cantell and 52) of the murine respiratory Sendai virus (SeV) with differential abilities to induce type I IFN production from infected cells, together with type I IFN receptor-deficient mice, we examined the role of type I IFNs in the generation of adaptive immunity. Our results show that type I IFNs facilitate virus clearance and enhance the migration and maturation of dendritic cells after SeV infection in vivo; however, soon after infection, mice clear the virus from their lungs and efficiently generate cytotoxic T cells independently of type I IFN signaling. Furthermore, animals that are unresponsive to type I IFN develop long-term anti-SeV immunity, including CD8+ T cells and antibodies. Significantly, this memory response is able to protect mice against challenge with a lethal dose of virus. In conclusion, our results show that primary and secondary anti-SeV adaptive immunities are developed normally in the absence of type I IFN responsiveness.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611914      PMCID: PMC1472017          DOI: 10.1128/JVI.80.9.4538-4545.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

Authors:  A Le Bon; G Schiavoni; G D'Agostino; I Gresser; F Belardelli; D F Tough
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

2.  Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.

Authors:  Taro Kawai; Shintaro Sato; Ken J Ishii; Cevayir Coban; Hiroaki Hemmi; Masahiro Yamamoto; Kenta Terai; Michiyuki Matsuda; Jun-ichiro Inoue; Satoshi Uematsu; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2004-09-07       Impact factor: 25.606

Review 3.  Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9.

Authors:  Tomoki Ito; Yui-Hsi Wang; Yong-Jun Liu
Journal:  Springer Semin Immunopathol       Date:  2004-11-13

Review 4.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways.

Authors:  Winfried Barchet; Anne Krug; Marina Cella; Celeste Newby; Jens A A Fischer; Andrzej Dzionek; Andrew Pekosz; Marco Colonna
Journal:  Eur J Immunol       Date:  2005-01       Impact factor: 5.532

6.  MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection.

Authors:  Shenghua Zhou; Evelyn A Kurt-Jones; Leisa Mandell; Anna Cerny; Melvin Chan; Douglas T Golenbock; Robert W Finberg
Journal:  Eur J Immunol       Date:  2005-03       Impact factor: 5.532

7.  Synthesis of (2'-5')oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus.

Authors:  T W Nilsen; P A Maroney; C Baglioni
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

8.  Production of interferon-alpha induced by dsRNA in human peripheral blood mononuclear cell cultures: role of priming by dsRNA-induced interferons-gamma and -beta.

Authors:  J L Lepe-Zuniga; J Rotbein; J U Gutterman
Journal:  J Interferon Res       Date:  1989-08

9.  Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN.

Authors:  Maria Montoya; Matthew J Edwards; Delyth M Reid; Persephone Borrow
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

10.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  26 in total

1.  Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice.

Authors:  Annie Elong Ngono; Edward A Vizcarra; William W Tang; Nicholas Sheets; Yunichel Joo; Kenneth Kim; Matthew J Gorman; Michael S Diamond; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2017-01-11       Impact factor: 21.023

Review 2.  Toll-like receptor-independent triggering of dendritic cell maturation by viruses.

Authors:  Carolina B López; Jacob S Yount; Thomas M Moran
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon.

Authors:  Jaime L Wetzel; Volker Fensterl; Ganes C Sen
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

4.  Identification of key genes and signaling pathways during Sendai virus infection in vitro.

Authors:  Wenqiang Wei; Wanting Kong
Journal:  Braz J Microbiol       Date:  2018-12-17       Impact factor: 2.476

5.  Highly immunostimulatory RNA derived from a Sendai virus defective viral genome.

Authors:  Xiomara Mercado-López; Christopher R Cotter; Won-Keun Kim; Yan Sun; Luis Muñoz; Karla Tapia; Carolina B López
Journal:  Vaccine       Date:  2013-10-05       Impact factor: 3.641

6.  Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes.

Authors:  Mahesh Chemudupati; Adam D Kenney; Anna C Smith; Robert J Fillinger; Lizhi Zhang; Ashley Zani; Shan-Lu Liu; Matthew Z Anderson; Amit Sharma; Jacob S Yount
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

7.  Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells.

Authors:  Derek D C Ireland; Stephen A Stohlman; David R Hinton; Roscoe Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

8.  Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection.

Authors:  Jacquelyn R Bedsaul; Luna A Zaritsky; Kathryn C Zoon
Journal:  J Interferon Cytokine Res       Date:  2016-08-10       Impact factor: 2.607

9.  A protective role for dengue virus-specific CD8+ T cells.

Authors:  Lauren E Yauch; Raphaël M Zellweger; Maya F Kotturi; Afrina Qutubuddin; John Sidney; Bjoern Peters; Tyler R Prestwood; Alessandro Sette; Sujan Shresta
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

10.  Distinct Chronic Post-Viral Lung Diseases upon Infection with Influenza or Parainfluenza Viruses Differentially Impact Superinfection Outcome.

Authors:  Geyon L Garcia; Alex Valenzuela; Tomaz Manzoni; Andrew E Vaughan; Carolina B López
Journal:  Am J Pathol       Date:  2019-12-19       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.